BRIEF published on 01/06/2025 at 18:05, 1 year 3 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Transparency Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
BRIEF published on 01/06/2025 at 18:05, 1 year 3 months ago Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC Actionnariat Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE published on 01/06/2025 at 18:00, 1 year 3 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion NV received a transparency notification from Atlas Special Opportunities, LLC revealing a stake above 15% threshold due to purchase of voting securities Transparency Notification Biopharmaceutical Atlas Special Opportunities Ophthalmic Therapies Oxurion NV
PRESS RELEASE published on 01/06/2025 at 18:00, 1 year 3 months ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC Oxurion NV receives transparency notification from Atlas Special Opportunities LLC regarding ownership of 624,817 shares, exceeding the 15% threshold Transparency Notification Share Ownership Atlas Special Opportunities LLC Oxurion NV Ophthalmological Therapies
BRIEF published on 01/03/2025 at 18:05, 1 year 3 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Shares Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
BRIEF published on 01/03/2025 at 18:05, 1 year 3 months ago Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC Actions Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE published on 01/03/2025 at 18:00, 1 year 3 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion NV received a transparency notification under Belgian Transparency legislation from Atlas Special Opportunities, LLC, regarding the sale of voting securities Transparency Notification Atlas Special Opportunities LLC Oxurion NV Belgian Legislation Retinal Disease Therapy
PRESS RELEASE published on 01/03/2025 at 18:00, 1 year 3 months ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC Oxurion NV announces receipt of transparency notification regarding shareholding. Bio-pharmaceutical company developing ophthalmological therapies. Refer to website for more details Transparency Notification Shareholding Belgium Oxurion NV Ophthalmological Therapies
BRIEF published on 12/31/2024 at 18:05, 1 year 3 months ago Oxurion reporte une transaction stratégique en raison de discussions en cours Report Transaction Stratégique Oxurion Discussions Financières Louvain
BRIEF published on 12/31/2024 at 18:05, 1 year 3 months ago Oxurion Postpones Strategic Transaction Due to Ongoing Discussions Report Strategic Transaction Oxurion Leuven Financial Discussions
Published on 04/18/2026 at 04:00, 1 day 4 hours ago Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Published on 04/18/2026 at 02:00, 1 day 6 hours ago AI/ML Innovations Announces Completion of Share Issuance
Published on 04/18/2026 at 01:35, 1 day 7 hours ago Medicure Announces Resignation of President and Chief Operating Officer
Published on 04/18/2026 at 01:00, 1 day 7 hours ago Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Published on 04/18/2026 at 00:00, 1 day 8 hours ago Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia
Published on 04/18/2026 at 00:05, 1 day 8 hours ago ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Published on 04/17/2026 at 21:39, 1 day 11 hours ago Linedata Services: Mise à disposition du Document d’Enregistrement Universel 2025 incluant le Rapport Financier Annuel 2025
Published on 04/17/2026 at 20:33, 1 day 12 hours ago LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors
Published on 04/17/2026 at 19:30, 1 day 13 hours ago KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS
Published on 04/17/2026 at 20:30, 1 day 12 hours ago ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/17/2026 at 19:00, 1 day 13 hours ago Cegedim : Publication du Document d’Enregistrement Universel 2025
Published on 04/17/2026 at 19:00, 1 day 13 hours ago Cegedim: Release of its 2025 Universal Registration Document
Published on 04/17/2026 at 17:45, 1 day 15 hours ago Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın
Published on 04/17/2026 at 17:45, 1 day 15 hours ago Carrefour annonce la cession de sa participation minoritaire dans CarrefourSA en Turquie à Aydın
